Position in GERN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$212,498
-$116,201 QoQ
Shares Held
166,015
-24.7% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 259 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 2%
Shared 0%
None 98%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Derivatives in GERN
reported options exposure · as of Dec 31, 2020CallValue
$1,590
CallShares
1,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Creative Planning holds $452,608,635 across 219 Biotechnology names. GERN ranks #167 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
127,672 | $63,418,511 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,949 | $23,039,178 | |
| 3 | EXEL |
Exelixis, Inc.
|
270,292 | $14,706,586 | |
| 4 | INCY |
Incyte Corp
|
110,664 | $12,544,870 | |
| 5 | CYTK |
Cytokinetics Inc
|
141,939 | $12,091,783 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
64,120 | $12,008,393 | |
| 7 | ARGX |
Argenx SE
|
12,744 | $11,823,500 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
153,161 | $8,763,872 |
All Filings in GERN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $212,498 | 166,015 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $328,699 | 220,604 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $269,078 | 203,847 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $477,566 | 348,589 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $503,971 | 357,427 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $169,612 | 106,675 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $235,979 | 66,661 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $421,239 | 92,784 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $317,775 | 74,947 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $115,592 | 35,028 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $60,803 | 28,817 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $26,281 | 12,397 | Shares | Sole | 2023-11-16 | |
| 2021-03-31 | $306,935 | 194,263 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $1,590 | 1,000 | Call | Sole | 2021-01-29 | |
| 2020-12-31 | $181,678 | 114,263 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $1,740 | 1,000 | Call | Sole | 2020-11-05 | |
| 2020-09-30 | $696 | 400 | Put | Sole | 2020-11-05 | |
| 2020-09-30 | $200,153 | 115,031 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $227,550 | 104,381 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $100,532 | 84,481 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||